Proton pump inhibitors on pancreatic cancer risk and survival

Conclusions Long-term PPI therapy may be associated with pancreatic cancer risk. While PPI users recently started on treatment had a slightly worse survival, this result likely is from reverse causation.
Source: Cancer Epidemiology - Category: Cancer & Oncology Source Type: research